Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer02:18

Cancer

48.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.4K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Social determinants of early childhood development in The Gambia: a multi-level analysis of household, maternal, and healthcare factors.

BMC public health·2026
Same author

Carboplatin Elicits ROS Responses and Potentially Regulates Translation Program in Cancer Systems.

Journal of biochemical and molecular toxicology·2026
Same author

Conjugation as an evolutionary bottleneck in antimicrobial resistance spread.

Frontiers in microbiology·2026
Same author

Prevalence of RSV among patients in tertiary hospitals and healthcare worker knowledge in The Gambia: A paradigm shift from reactive to proactive 3PM-guided care is envisaged.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Molecular and cellular landscapes of the immune microenvironment and multiomic biomarker-sets in platinum-resistant recurrent ovarian cancers.

Journal of ovarian research·2026
Same author

Non-intubated video-assisted thoracic surgery for operable lung cancer: a randomized controlled trial.

International journal of surgery (London, England)·2026

Related Experiment Video

Updated: Jun 8, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.3K

Cancer metabolic reprogramming and precision medicine-current perspective.

Tingting Gao1, Liuxin Yang2, Yali Zhang1

  • 1Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, China.

Frontiers in Pharmacology
|November 1, 2024
PubMed
Summary

Cancer metabolic reprogramming (MR) offers new ways to predict treatments. Understanding these metabolic changes is key for personalized cancer medicine and improving patient outcomes.

Keywords:
immune cellmechanismmetabolic reprogrammingprecision medicinetreatment strategies

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.1K

Related Experiment Videos

Last Updated: Jun 8, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.3K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.1K

Area of Science:

  • Oncology
  • Metabolic Research
  • Translational Medicine

Background:

  • Cancer remains a leading cause of death globally, impacting socio-economic development.
  • Existing treatments, including combination therapies, face challenges due to cancer's resilience.
  • Cancer cell proliferation is fueled by unique metabolic profiles specific to cancer type and patient.

Purpose of the Study:

  • To review recent advancements in cancer metabolic reprogramming (MR).
  • To highlight the role of MR in predictive, preventive, and precision medicine.
  • To discuss current perspectives on cancer MR mechanisms and personalized treatment strategies.

Main Methods:

  • Literature review of recent advancements in cancer metabolic reprogramming.
  • Analysis of current perspectives on cancer MR mechanisms.
  • Exploration of the role of MR in personalized cancer medicine.

Main Results:

  • Metabolic reprogramming (MR) is a critical factor in cancer proliferation.
  • MR offers insights into predicting effective cancer treatments.
  • Advancements in understanding cancer MR contribute to precision medicine.

Conclusions:

  • Understanding cancer-specific metabolic profiles is essential for effective treatment.
  • Metabolic reprogramming is a promising avenue for developing personalized cancer therapies.
  • Optimizing metabolic outputs is crucial for advancing personalized cancer medicine.